MARYLAND HEIGHTS, MO / CRWEPRESSRELEASE / August 13, 2015 /Lee Biosolutions is a healthcare biotech company that manufactures finished proteins for the research and clinical diagnostic and life science market. Today we are proud to announce the promotion of Matthew Lee as President and Chief Operating Officer on August 12, 2015.
Burton Lee, Chief Executive Officer of Lee Biosolutionsstated, “Matt’s leadership skills and business acuity has helped us maintain double digit growth and increased profitability allowing us to expand our operations. His dedication to our team, vendors and customers has made this management move as the most logical choice in order to maximize our potential for growth.” Burton Lee will maintain his role as CEO and focus on strategic planning.
Matthew Lee holds a B.S. in Marketing Management from Missouri State University and joined Lee Biosolutions in 2012 as Logistics Manager. He was promoted to Vice-President of Business Operations in 2014 for his ability to improve operational efficiencies in the business. He is currently on the Board of Directors and not only continue running the day to day operations but will assist the CEO in applying creative solutions to strategic challenges.
About Lee Biosolutions, Inc.
We are a global healthcare biotech company that specializes in process development and bulk manufacturing of finished human and animal enzymes and related proteins for research and clinical diagnostic tests. Our products are used for such pathologies as cardiac disease, cancer, diabetes, urine analysis, coagulation, obesity, inflammatory, neurological, autoimmune diseases and immunological disorders. Our expertise includes process optimization and scale-up, bioanalytical development, validation and purification of biologicals. We are known for our ability to take a bench top pilot process and scale up to commercialization that is efficient and cost effective for our clients.
SOURCE: Lee Biosolutions, Inc.